Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.940
+0.140 (7.78%)
At close: May 12, 2025, 4:00 PM
1.930
-0.010 (-0.52%)
After-hours: May 12, 2025, 7:59 PM EDT
INO's stock price has decreased by -81.78% in the past year and price targets may not have had time to catch up.
Inovio Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$12.20
Upside
+528.87%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +157.73% | Mar 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $3 | Hold | Reiterates | $3 | +54.64% | Mar 19, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +827.84% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +54.64% | Jan 13, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +827.84% | Jan 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $12 → $5 | Hold | Maintains | $12 → $5 | +157.73% | Nov 18, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $33 → $15 | Buy | Maintains | $33 → $15 | +673.20% | Nov 18, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $7 → $6 | Hold | Maintains | $7 → $6 | +209.28% | Nov 15, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | +260.82% | Oct 4, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 → $33 | Buy | Maintains | $40 → $33 | +1,601.03% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $11 → $8 | Hold | Maintains | $11 → $8 | +312.37% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $15 | Hold | Reiterates | $15 | +673.20% | Jul 15, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $20 | Buy | Initiates | $20 | +930.93% | May 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +1,961.86% | Mar 8, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $11 | Hold | Reiterates | $11 | +467.01% | Mar 7, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $4 | Hold → Buy | Upgrades | $4 | +106.19% | Jan 25, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.